Nucleus RadioPharma, the world’s first fully integrated development, manufacturing, and supply chain organization for radiopharmaceuticals, has announced that it has signed a lease and committed to build a new manufacturing facility in southeast Mesa. Once operational in mid-2026, the 53,000-square-foot facility will create 50 new skilled jobs.
The theranostic market currently faces a shortage of high-quality development and manufacturing space capable of meeting the volume needs of radiopharmaceutical treatments used in late-stage clinical trials, as well as those in the development pipeline that will soon receive regulatory approvals. Nucleus’ new space will help fulfill both of those needs, allowing its partners to produce crucial theranostics across the country. Nucleus will also build a new facility in Philadelphia for a total of more than 100,000-square-feet of capacity between the two new sites. Once operational, the sites will allow Nucleus to more fully realize its commitment to a nationwide network capable of serving the ever-growing demand for theranostics across the U.S. ahead of the Rochester, MN site that will come online in early 2025.
“To reach their full potential as treatments for millions of patients who have otherwise limited options, it’s vital that theranostic radiopharmaceuticals are available in places close to the people who need them,” said Nucleus RadioPharma CEO Charles S. Conroy. “Nucleus is proud to lead the way in making that a reality, beginning with these facilities near Phoenix and Philadelphia. We’re confident this move will help expedite clinical trials for theranostics and potentially get these life-saving products to market even sooner.”
“Nucleus RadioPharma’s new manufacturing facility highlights Arizona’s thriving bioscience industry that’s developing cutting-edge innovations to improve people’s lives,” said Sandra Watson, President and CEO of the Arizona Commerce Authority. “With this new facility, Nucleus RadioPharma strengthens Arizona’s bioscience leadership while developing breakthrough treatments for patients. We’re grateful to Nucleus RadioPharma for their commitment to Arizona.”
“We’re excited to welcome Nucleus RadioPharma's new facility to Mesa,” said Mesa Mayor John Giles. “Their investment brings dozens of well-paying jobs to our city, boosting our local economy and enhancing our reputation as a hub for innovation. This expansion opens new doors for our local workforce and underscores Mesa's role in supporting cutting-edge technology development. I'm confident this partnership will have long-lasting benefits for our community as well as patients across the nation.”
“Cancer has impacted countless families, including mine, so today's announcement resonates deeply with me,” said Mesa Councilmember Scott Somers. “Nucleus RadioPharma’s presence in Mesa isn’t just about economic growth—it’s about hope. This facility will create advanced manufacturing jobs and ensure the steady supply of life-saving medications to help more people fight and overcome this disease.”
